Recommended
Posted: 28 February 2020 |
RecommendedTeva close to API business saleFirst new IPF treatment in US for a decadeWebinar: Radiopharmaceuticals’ time-to-result challengeAstraZeneca/Daiichi cancer drug boostTakeda to move away from cell therapyGSK appoints new CEO